AVADEL PHARMACEUTICALS PLC shareholders Q2 2023

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 101 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2023. The put-call ratio across all filers is 0.87 and the average weighting 0.6%.

AVADEL PHARMACEUTICALS PLC shareholders Q2 2023
NameSharesValueWeighting ↓
QP WEALTH MANAGEMENT, LLC 13,380$220,5020.35%
Modera Wealth Management, LLC 594,000$9,789,1200.18%
KENNEDY CAPITAL MANAGEMENT LLC 446,720$7,361,9460.17%
State of Wyoming 34,959$576,1240.17%
Carmichael Hill & Associates, Inc. 21,000$346,0800.16%
Shay Capital LLC 66,000$1,087,6800.15%
Blue Zone Wealth Advisors, LLC 15,000$247,2000.11%
Shay Capital LLC 45,000$741,6000.10%
ADAGE CAPITAL PARTNERS GP, L.L.C. 2,680,000$44,166,4000.10%
JANUS HENDERSON GROUP PLC 7,522,545$124,010,8910.08%
IRIDIAN ASSET MANAGEMENT LLC/CT 45,586$751,2570.07%
J. Goldman & Co LP 108,000$1,779,8400.06%
Aaron Wealth Advisors LLC 22,642$373,1400.05%
J.P. Morgan Private Wealth Advisors LLC 500,000$8,240,0000.04%
Point72 Asset Management, L.P. 676,260$11,144,7650.03%
MARSHALL WACE, LLP 609,026$10,036,7490.02%
Caption Management, LLC 67,193$1,107,3410.02%
J. Goldman & Co LP 28,773$474,1790.02%
Renaissance Technologies 692,106$11,4060.02%
Carmichael Hill & Associates, Inc. 2,000$32,9600.02%
External links

This page lists AVADEL PHARMACEUTICALS PLC's shareholders in Q2 2023. To view AVADEL PHARMACEUTICALS PLC's shareholder history, click here.